Detalhe da pesquisa
1.
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
Nature
; 468(7320): 93-7, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20962779
2.
Targeting C-reactive protein for the treatment of cardiovascular disease.
Nature
; 440(7088): 1217-21, 2006 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16642000
3.
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.
Circ Res
; 97(11): e97-103, 2005 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-16254214
4.
Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.
Atherosclerosis
; 196(1): 248-255, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17588586
5.
Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.
J Infect Dis
; 193(8): 1120-4, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16544252
6.
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.
Proc Natl Acad Sci U S A
; 102(23): 8309-14, 2005 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-15919817
7.
Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice.
J Immunol
; 171(11): 6046-51, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14634117